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RGS (regulator of G protein signaling) proteins containing the G
protein -like (GGL) domain (RGS6, RGS7, RGS9, and RGS11) inter-
act with the fifth member of the G protein -subunit family, G5.
This interaction is necessary for the stability of both the RGS
protein and for G5. Consistent with this notion, we have found
that elevation of RGS9-1 mRNA levels by transgene expression
does not increase RGS9-1 protein level in the retina, suggesting
that G5 levels may be limiting. To examine further the interac-
tions of G5 and the GGL domain-containing RGS proteins, we
inactivated the G5 gene. We found that the levels of GGL
domain-containing RGS proteins in retinas and in striatum are
eliminated or reduced drastically, whereas the levels of G2 and
RGS4 proteins remain normal in the absence of G5. The homozy-
gous G5 knockout (G5) mice derived from heterozygous
knockout mating are runty and exhibit a high preweaning mor-
tality rate. We concluded that complex formation between GGL
domain-containing RGS proteins and the G5 protein is necessary
to maintain their mutual stability in vivo. Furthermore, in the
absence of G5 and all four RGS proteins that form protein
complexes with G5, the animals that survive into adulthood are
viable and have no gross defects in brain or retinal morphology.
F irst discovered functionally as negative regulators of Gprotein signaling in Saccharomyces cerevisiae (Sst2p) (1) and
Caenorhabditis elegans (EGL10) (2), RGS (regulator of G pro-
tein signaling) proteins accelerate the hydrolysis of GTP by the
-subunits of heterotrimeric G proteins (3). They form a large
gene family with a diagnostic120-aa RGS domain in which the
GTPase-accelerating activity resides (4). In addition to the RGS
domain, most RGS proteins possess additional domains that
enable them to interact with other cellular signaling molecules
(5). A subgroup of the RGS family, namely RGS9, RGS11,
RGS7, and RGS6, possesses a G -like (GGL) domain that binds
the fifth member of the heterotrimeric G protein -subunit
(G5) both in vitro and in vivo (6–10). There are five known
members of the G protein -subunit family (11, 12). The first
four members, G1–4, are highly similar, sharing 80–90% se-
quence identity. G5 is the most divergent member of this
family, sharing only 50% sequence identity with G1–4. G5
exists in two forms: the common, short-splice form (G5-S) and
a unique, long-splice form (G5-L) that exists exclusively in
retinal photoreceptors. The long form results from the addition
of an N-terminal exon through alternative splicing (11). G5
complexes with either GGL domain-containing RGS proteins or
with certain G protein -subunits such as G2 (12, 13). Likewise,
the GGL domain-containing RGS proteins not only interact with
G5, they also can interact with other proteins such as polycystin
(for RGS7) (14) and SCG10 (for RGS6) (15). Interestingly, these
RGS proteins do not interact with G1–4, indicating that their
interaction with G5 is selective and may be important for their
in vivo function (6, 16). In C. elegans, the G5 ortholog, GPB-2,
is required for the activity of the two GGL domain-containing
RGS proteins, EGL-10 and EAT-16 (17–19). GPB-2 protein
level is reduced significantly in eat-16; egl-10 double-mutants.
Similarly, the EGL-10 protein is diminished severely in gpb-2
mutants (17). These data indicate that in worms the interactions
between GPB-2 and EGL-10 or EAT-16 confer mutual stability
to these proteins.
In retinal photoreceptors, the complex of G5 and RGS9-1
modulates the intrinsic GTPase activity of transducin (20, 21). In
mice lacking functional RGS9 genes (RGS9 mice), the
recovery phase of both rod and cone phototransduction is
prolonged abnormally because of slowed GTP hydrolysis by rod
and cone transducin (22, 23). RGS9 exists in two forms through
alternative splicing: a 55-kDa retinal-specific form, RGS9-1,
containing a unique C-terminal domain, and an 81-kDa striatal
form, RGS9-2, possessing a different and longer C-terminal
domain (24, 25). The G5-L protein disappears in RGS9
retinas but the G5-L mRNA level is normal, indicating that
RGS9-1 is required to maintain a normal G5-L protein level in
vivo (22). However, the level of the short G5-S in the striatum
appears normal despite the absence of RGS9-2 in the RGS9
mice (Fig. 1). The specific loss of G5-L in RGS9 mice may
be attributed to its exclusive expression in retinal photorecep-
tors. Interestingly, the RGS9-1G5-L complex is present more
abundantly in cones than in rods (26, 27). Such a difference has
been suggested to account, at least in part, for the faster
cone-flash responses. In this report, we have overexpressed the
RGS9-1 mRNA in mouse retinal photoreceptors and found that
elevation of the RGS9-1 mRNA level did not increase the
RGS9-1 protein level. In addition, we demonstrated that G5 is
required to maintain the in vivo levels of GGL domain-
containing RGS proteins but not regular G-subunits or RGS
protein without a GGL domain. These data establish in vivo that
G5 and GGL domain-containing RGS proteins are obligate
partners and support the notion that G5 functions as a com-
ponent of the GAP (GTPase-accelerating protein) complex,
rather than as the -subunit component of heterotrimeric G
proteins.
Materials and Methods
Gene Targeting. All experimental procedures involving the pro-
duction and use of laboratory mice complied with National
Institutes of Health guidelines as approved by the Institutional
Animal Care and Use Committee of the California Institute of
Technology and the University of Utah. Standard procedures
were used to generate G5 mice (28). Briefly, the mouse
G5 gene was inactivated by replacing a 2.7-kb XhoI genomic
fragment encompassing the third exon of the G5 gene with a
neomycin (Neo)-resistant marker as shown in Fig. 2 A. The
genomic fragments flanking the Neo marker for driving homol-
ogous recombination were 1.5 and 7.4 kb in length. The targeting
construct, pCKC-G5KO-direct, was introduced into mouse
CJ-7 embryonic stem cells by electroporation and selected with
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G418 for 7 days. Cells in which homologous recombination had
occurred were identified by the presence of a 2.1-kb PCR
product by using primers G5KO1: 5-ACA GTC CTA ATG
GCC CAG GTG and Neo3: 5-CGA GGA TCT CGT CGT GAC
CCA. The PCR conditions used were 94°C for 3 min followed by
35 cycles of 94°C for 1 min, 58°C for 1 min, and 72°C for 3 min,
followed by a final extension of 10 min at 72°C. The targeted
embryonic stem cells were injected into blastocysts derived from
C57BL6 strain, and the chimeric mice were mated with
C57BL6 or 129SvEv mice to generate heterozygous knockout
(G5) mice in both outbred and inbred genetic backgrounds,
respectively. The outbred and inbred homozygous knockout
(G5) mice were produced by intercross of the G5 mice
within their respective genetic backgrounds.
Transgenic Mice. To express RGS9-1 in mouse photoreceptors,
the coding region of the RGS9-1 cDNA was cloned downstream
of a 4-kb mouse opsin promoter fragment in the pRho4.2 vector
and upstream of the mouse protamine polyadenylation signal by
using ClaIBamHI sites (Fig. 6A). The 4-kb mouse opsin pro-
moter fragment has been used extensively in transgenic studies
to drive photoreceptor specific gene expression (29–32). The
6-kb KpnIXbaI DNA fragment containing the promoter, the
RGS9-1-coding region, and the polyadenylation signal was in-
jected into B6D2 F1 embryos. The founder mice, TG9F2 and
TG9F10, were identified by the presence of a 330-bp PCR
product by using primers 3ms9: 5-GGC GTC TGA AAT CGG
TAG AGA and RGS9-1: 5-ATG ACG ATC CGA CAC CAA
GGC. The PCR conditions used were as follows: 94°C for 3 min
followed by 30 cycles of 94°C for 1 min, 58°C for 1 min, and 72°C
for 1 min, and a final extension period of 10 min at 72°C. To
generate TG9F2 and TG9F10 mice, the TG9F2 and
TG9F10 mice were crossed into the RGS9 background
through two generations of breeding. The wild-type RGS9 allele
was identified by the presence of a 480-bp PCR product by using
primers DD2: 5-GTA ACA GCT GCT GTT CCA AAA ATC
and RGS9-6: 5-TGC ATT CTG ACT CCC GTC TCT GGG.
The targeted RGS9 allele was identified by the presence of a
300-bp PCR product by using primers RGS9KO1: 5- CGG CGA
GGA TCT CGT CGT GAC and RGS9KO2: 5-GAA CAA
ACG ACC CAA CAC CCG. The PCR conditions used for
genotyping RGS9 mice were identical to those used for
TG9F10.
Antibody Production. Polyclonal antibody for RGS11, s-11, was
raised in rabbits against recombinant mouse RGS11 fragment
(residues 248–471, including the RGS and the C-terminal do-
mains) and affinity-purified by immobilized antigen. The poly-
clonal antibody for RGS6, CT-3159, was raised in chicken against
RGS6 peptide (CAKKKGKSLAGKRLTG) conjugated to key-
hole limpet hemocyanin and affinity-purified by using immobi-
lized peptide on SulfoLink resin (Pierce).
Immunoblots. Approximately 20g of total retinal proteins or 100
g of striatal proteins, determined by Pierce BCA kit by using
BSA as a standard, was resolved by SDSPAGE followed by
Western blotting onto nitrocellulose membrane. The dilutions of
antibodies used for detection were: CT-215 (anti-G5, used at
1:2,500); CT-317 (RGS9-1 specific, 1:1,000); R4432 (generic
RGS9 antibody, 1:5,000); SC-6204 (anti-RGS4, 1:200; Santa
Cruz Biotechnology); SC-374 (anti-G2, 1:200; Santa Cruz Bio-
technology); 2923AP (anti-RGS7, 1:5,000; Upstate Biotechnol-
ogy); s-11 (anti-RGS11, 1:1,000); and CT-3159 (anti-RGS6,
1:1,000). For the detection of RGS6, 40 g of retinal extract
was used.
Northern Blots. Total RNAs from retina and striatum were
isolated by using the Trizol reagent (Invitrogen) by following the
manufacturer’s instructions. The RNA was denatured by glyoxal,
fractionated on agarose gels, and blotted onto positively charged
nylon membranes (Roche, Gipf-Oberfrick, Switzerland). PCR-
generated DNA fragments containing the N-terminal coding
sequences of RGS9 (1–350), RGS11 (1–350), RGS7 (1–350), and
RGS6 (1–400) were used as templates to synthesize radioactive
probes by using the Takara Ladderman DNA-labeling kit
(Takara Shuzo, Kyoto). Hybridization of the probes to the nylon
membranes was carried out in the ExpressHyb solution (CLON-
TECH) at 68°C for 1 h. The membranes then were washed with
2 SSC0.1% SDS at room temperature for 30 min, followed by
0.1 SSC0.1% SDS at 54°C for 30 min. The signals were
visualized by autoradiography by using Kodak BioMax MS film.
Results
Lack of G5-L but Not G5-S in RGS9Mice. It has been shown that
the G5-L protein, but not its mRNA, is absent in the retina of
RGS9 mice (22). We found that the level of the short-splice
form, G5-S, is not affected by the inactivation of the RGS9 gene
in retina or in striatum (Fig. 1). In the retina, G5-S resides in
different cell types other than photoreceptors and interacts with
other GGL domain-containing RGS proteins such as RGS7 (9).
This may stabilize the G5-S protein (10). Similarly, in the
striatum, other GGL domain-containing RGS proteins may
compensate for the loss of RGS9-2, or perhaps RGS9-2 consti-
tutes only a small fraction of the total GGL domain-containing
RGS proteins.
Inactivation of G5 Gene. To examine whether the interaction
observed for the RGS9-1G5-L protein complex in retinal
photoreceptors applied to the short-splice variant G5-S and to
other GGL domain-containing RGS proteins, we inactivated the
G5 gene. As shown in Fig. 2A, a genomic 2.7-kb XhoI fragment
containing the third exon of G5 gene was replaced with a 1.1-kb
Neo resistance marker in the gene-targeted mice. We made both
outbred (mixed background of C57BL6 and 129SvEv) and
inbred (129SvEv) heterozygous knockout (G5) lines. The
homozygous G5 knockout (G5) lines were generated by
intercross of the G5 mice and maintained in both outbred
and inbred backgrounds. Inactivating one copy of the G5 gene
did not change the G5 protein levels in retina (Fig. 2B) or in
brain (data not shown), whereas no G5 protein was detectable
Fig. 1. The presence of G5-S in the retina and striatum of RGS9 mice.
Retinal extracts (20 g) and striatal extracts (CPu, 100 g) from wild-type and
RGS9 mice (indicated, Top) were resolved by 12% SDSPAGE, and the
presence of G5 and RGS9 spliced forms were visualized by Western blots by
using generic RGS9 antibody (R4432) and G5 antibody (CT-215). Molecular
mass markers (top to bottom: 124, 81, 50, and 42 kDa) are shown on the left.
The splice variants of RGS9 and G5 are indicated by arrows (top to bottom,
RGS9-2, RGS9-1, G5-L, and G5-S).
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in the homozygous knockout mice. The G5 mice derived
from the mating of heterozygous knockout parents could be
identified readily as runty among their normal and G5
littermates. More than two-thirds of the G5 pups died by
the time of weaning at 21 days of age. However, we were able to
establish both outbred and inbred homozygous knockout lines by
hand-feeding and further breeding of the surviving G5
mice. The offspring of the G5 mice were smaller in size and
displayed slower weight gain in the first month of age (Fig. 3).
A period of no weight gain just before weaning (from 15 to 20
days of age) coincided with the time of abnormally high mortality
rate observed for the G5 mice. At 3 months of age, they
lacked obvious morphological abnormalities in retina and brain.
Instability of GGL Domain-Containing RGS Proteins but Not Their
Messenger RNA in G5 Mice. The inactivation of G5 gene did
not affect the steady-state mRNA levels of the GGL domain-
containing RGS genes in the retina (Fig. 4A) or in the striatum
(Fig. 5A). However, the levels of these RGS proteins fell
significantly (e.g., RGS9-1 in the retina; Fig. 4B) or were not
detectable (RGS9-2, RGS-6, RGS7, and RGS11; Fig. 4B). In the
retina, the RGS9-1 protein level in G5 mice was 5% of
that in the normal mice. A similar level of residual RGS9-1 also
was found in inbred G5 mouse retinas (data not shown). In
the striatum, both the RGS9-2 and the RGS7 proteins were
absent, whereas their messenger RNA levels remained unaf-
fected (Fig. 5). The message levels of RGS6 and RGS11 in the
wild-type striatum were reportedly low (33) and fell below our
detection limits (data not shown). The absence of RGS7 protein
but not its messenger RNA in the cerebellum or in the whole
brain also was observed (data not shown). The instabilities were
restricted to GGL domain-containing RGS proteins because the
level of another RGS protein without the GGL domain, RGS4,
was not affected by the loss of G5 (Fig. 5C). The level of G2,
a member of the G protein -subunit family, which forms a
heterodimer with G5 that activates phospholipase in vitro (12,
34), also was not affected by the loss of G5 (Fig. 5C).
Lack of RGS9-1 Overexpression in RGS9-1 Transgenic Mice. In an
attempt to alter the response kinetics of rod photoreceptors and
to further explore the relationship between G5-L and RGS9-1,
we sought to overexpress RGS9-1 in mouse photoreceptors. We
made a transgenic construct containing a 4-kb mouse opsin
promoter fragment to drive the transcription of RGS9-1 cDNA
(Fig. 6A) and used it to generate transgenic mice. Two founders
were obtained, TG9F2 and TG9F10, which transmitted the
transgene to their offspring. Dot-blot analysis demonstrated that
the level of the RGS9-1 mRNA derived from the transgenes was
2- to 8-fold higher than that derived from the endogenous
RGS9 genes (Fig. 6B). However, we did not observe a corre-
sponding increase in RGS9-1 protein level in the retina (Fig. 6C),
and the rod photoresponses appeared normal (data not shown).
The lack of RGS9-1 protein overexpression in TG9F2 and
TG9F10 transgenic mice may result from the failure of the
photoreceptors to translate the transgenic RGS9-1 mRNA. To
ensure that the transgenic messages were translated into protein
and that the transgenic RGS9-1 protein could interact with
endogenous G5-L, we bred the transgenic mice into the
RGS9 background. As shown in Fig. 6D, the resulting
transgenic lines, TG9F2 and TG9F10, were found to
express RGS9-1 protein in the retinas to20% and 100% of the
wild-type RGS9-1 protein level, respectively. The levels of
restoration of RGS9-1 protein in TG9F2 and TG9F10
mice were accompanied by the restoration of corresponding
levels of G5-L protein (Fig. 6D), indicating that the transgenic
RGS9-1 interacts with endogenous G5-L in vivo to stabilize
each other when they can form specific complexes.
Discussion
The Stability of the GGL Domain-Containing RGS Proteins Requires
G5. The failure to overproduce RGS9-1 protein in transgenic
TG9F10 and TG9F2 mouse retinas despite the elevated mRNA
level suggests that the amount of RGS9-1 protein in vivo is not
controlled by the levels of its transcripts. The protein level of
RGS9-1 apparently is controlled at the translation or posttrans-
lational levels. Several reports show that the regulation can occur
at the posttranslational level (10, 35). The disappearance of the
Fig. 2. The generation of G5 mice. (A) G5 gene-inactivation scheme.
(Top) The first half of the mouse G5 gene. (Middle) Targeting construct
replacing a 2.7-kb XhoI fragment with a Neo marker (hatched block). (Bottom)
The targeted locus can be identified by the presence of a 2.1-kb PCR fragment
when amplified by using Neo3 and G5-ko1 primers. (B) Western blotting of
20g of retinal extracts by using antibody CT-215 to show the presence of G5
proteins in various genetic backgrounds. The long-spliced form, G5-L, is
absent in RGS9 mouse retina, whereas both long and short forms of G5
are absent in G5 mice.
Fig. 3. The growth of G5mice in the first month of age. The mean body
weights of the G5 (‚, n  12) and G5 (, n  4) mice generated in
different litters were monitored daily after birth during their first month of
growth. All pups were weaned on postnatal day 21 (indicated by an arrow).
The smaller body size of the G5 pups is evident. In addition, a period of
no weight gain, from postnatal day 15 to 20 (indicated by a bar) in the G5
pups was noticed. Error bars represent SD.
6606  www.pnas.orgcgidoi10.1073pnas.0631825100 Chen et al.
GGL domain-containing RGS proteins in the retinas of GB5
mice lends further support to that notion. Apparently, G5 and
the GGL domain-containing RGS proteins are obligatory part-
ners in vivo. Such a relationship is not seen in other photore-
ceptor protein complexes such as the catalytic subunits of the
cGMP-phosphodiesterase (cG-PDE) found in mouse rods. In
rd1 mice carrying a non-sense mutation in the -subunit of
cG-PDE (36, 37), the -subunit of cG-PDE is still present in
rods, although in an inactive form (38, 39). The interaction
between GGL domain-containing RGS proteins and G5 as a
prerequisite for stability also applies to other regular G protein
 complexes (40) such as the G17 complex in HEK293 cells
(41). The interaction presumably shelters the proteins in these
complexes from being targeted for rapid degradation. The
mechanisms by which singular components are degraded remain
unclear.
The G5 Mice. The G5 pups have smaller body size
(runty) and an unusual mortality rate (66%) before weaning. By
hand-feeding the G5 pups starting at postnatal day 2 daily
with dough food and water, the preweaning mortality can be
circumvented, and the animals can survive into adulthood. Given
the widespread expression of G5 and the GGL domain-
containing RGS proteins in different parts of the nervous
system, we were surprised that we were able to establish a
G5 line. This result indicates that the GGL domain-
containing RGS proteins and G5 are not essential for the
development or the survival of the animal. However, the smaller
body size, slower weight gain, and the abnormally high mortality
rate indicate that these protein complexes clearly are important
for normal behavioral functions, presumably by regulating G
protein signaling in distinct neuronal circuits. By examining the
growth curve of the G5 mice, a period of no weight gain
between postnatal days 15 and 20 was noticed, which coincided
with the period of high mortality rate. It is not clear whether this
causes the G5 mice to die, but the establishment of the
G5 line enables us to examine this further. The G5
mice also can be used to study the physiological roles of the GGL
domain-containing RGS proteins under various experimental
conditions. An interesting question, for instance, is the function
of the residual level (5%) of RGS9-1 found in the retinal
photoreceptors of the G5 mice. A thorough electrophysi-
ological analysis currently is underway to elucidate the function,
if any, of the residual RGS9-1 in retinal photoreceptors.
Fig. 4. Instability of GGL domain-containing RGS proteins in retinas of G5 mice. (A) Retinal total RNA (3, 1.5, 0.75, and 0.38 g from left to right) isolated
from G5 and G5mice was hybridized with various radioactive probes specific for RGS9, RGS6, RGS7, and RGS11 by Northern blotting (see Materials and
Methods). The mRNA levels of the four RGS proteins were comparable between G5 and wild-type retinas. Molecular mass markers (in kb) are indicated at
right. (B) Western blotting of retinal protein extracts derived from different genetic backgrounds by using antibodies specific for individual RGS proteins
demonstrating the loss of RGS6, RGS7, and RGS11 and the reduction of RGS9-1 signals (indicated by arrows) in the G5 retina. Approximately 20g of retinal
extract was analyzed for RGS7, RGS11, and RGS9-1; 40 g was analyzed for RGS6 expression.
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The RGS9-1 Transgenic Mice. In C. elegans, overexpression of either
EGL-10 or EAT-16 produced noticeable effects in egg-laying
behavior (17). These data suggest that in worms, the GPB-2 level
is not limiting the amounts of functional EGL-10GPB-2 and
EAT-16GPB-2 protein complexes. Consistent with the notion
is that overexpression of GPB-2 has no obvious effect in related
behavior (19), although an effect in locomotion was noticed (18).
The lack of RGS9-1 protein overexpression despite elevated
mRNA level in retinas of the TG9F10 mice suggests that G5
limits the amount of the RGS9-1G5-L complex. Thus simul-
taneous expression of both proteins may be necessary to achieve
overexpression of this complex in photoreceptors. We notice that
the endogenous retinal RGS9-1 mRNA (Fig. 3) is significantly
longer than the striatal RGS9-2 mRNA (Fig. 4), whereas the
RGS9-1 protein is smaller than the RGS9-2 protein (Fig. 1). The
Fig. 5. The absence of RGS9-2 and RGS7 but not RGS4 and G2 in the striatum
of G5mice. (A) Northern blotting of total RNA (3, 1.5, 0.75, and 0.38g, left
to right) isolated from G5 and G5 striatum was hybridized with radio-
active RGS9 (Upper) and RGS7 (Lower) specific probes and visualized by autora-
diography. The level of the 2.6-kb RGS9-2 transcript and the 2.7-kb RGS7 tran-
script was similar in G5and in wild-type striatum. Molecular mass markers (in
kilobases) are indicated at left. (B and C) Western blotting of 100 g of striatal
extracts by using antibodies for RGS9 (R4432), RGS7 (2923AP), RGS4 (SC-6204),
and G2 (SC-374), showing the specific loss of the 82-kDa RGS9-2 and the 55-kDa
RGS7 signals in G5mice. The levels of a non-GGL domain RGS protein, RGS4,
and a regular -subunit, G2, are not affected by the absence of G5. Molecular
mass markers (in kilodaltons) are indicated on the left.
Fig. 6. RGS9-1 protein levels in TG9F transgenic mice. The pRho4.2-RGS9-1
transgenic construct shown in A was injected into mouse embryos to produce
TG9F2 and TG9F10 mice that express full-length RGS9-1-coding region in the
photoreceptors. The retinal levels of RGS9-1 transcripts were measured by dot
blot as shown in B. The amounts of total retinal RNAs blotted on the filter (top
to bottom) were 1, 0.5, 0.25, and 0.12 g, respectively. The RGS9-1 message
levels (Left) in TG9F2 and TG9F10 retinas were2- and 8-fold more than that
of the wild-type control. -Actin was used as a control for loading (Right). (C)
The RGS9-1 protein levels were determined by immunoblots of equal amount
of retinal extracts. (D) Western blot analyses showing the amounts of RGS9-1
(Left) and G5 spliced forms (Right) in retinas of indicated mouse lines. To
determine whether the transgenic RGS9-1 mRNA could be translated, TG9F2
and TG9F10 mice were bred into the RGS9 knockout background to produce
TG9F2 and TG9F10 mouse lines, respectively. The RGS9-1 protein level
in TG9F2 retina was20% of the wild-type level, whereas in TG9F10 it
was 100%. A corresponding restoration of G5-L in both TG9F2 and
TG9F10 mouse retinas was evident. Molecular markers (in kilodaltons) are
indicated on the right.
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role of the varied length of the noncoding region of endogenous
RGS9 mRNA is not known. However, we could detect only 20%
normal level of RGS9-1 protein whereas the level of RGS9-1
transgenic mRNA in the TG9F2 retina is 200% of the normal
level. Because the transgene contains only the coding region of
the RGS9-1 and apparently its mRNA is not translated as
efficiently as the endogenous one, this suggests that the non-
coding region of the endogenous RGS9-1 mRNA may contain
important elements for efficient translation. However, the par-
tial restoration of retinal RGS9-1G5-L protein level in
TG9F2 mice provides additional proof that these two pro-
teins form an obligatory complex and are required for their
mutual stability.
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